ACLY‐Driven Metabolic Reprogramming Promotes Histone Acetylation and Inflammation‐Associated Fibrosis in Chronic Kidney Disease
Advanced Science · 2026
DOI: 10.1002/advs.75247 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Chunxiu Du und 15 weiteren Autor:innen. Beteiligte Einrichtung: Institutes for Diabetes, Obesity and Metabolism, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Penns…. Hauptthemen laut MEDLINE: Histones, Renal Insufficiency, Chronic, ATP Citrate (pro-S)-Lyase, Kidney Tubules. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
The mechanisms by which metabolic stress drives epigenetic dysregulation and fibrosis in chronic kidney disease (CKD) remain incompletely understood. Using quantitative histone proteomics in murine fibrosis models, we uncovered a selective increase in histone H3 lysine 27 acetylation (H3K27ac) as a conserved epigenetic feature. Unbiased metabolomics revealed citrate accumulation, nominating ATP‐citrate lyase (ACLY) as a driver of acetyl‐CoA‐dependent histone acetylation. In murine models of folic acid and unilateral ureteral obstruction, ACLY expression, acetyl‐CoA levels, and H3K27ac were increased in injured kidneys. Tubule‐specific Acly deletion reduced acetyl‐CoA, H3K27ac, and attenuated tubulointerstitial fibrosis. Chromatin accessibility profiling revealed that loss of Acly decreased accessibility at pro‐inflammatory loci, including Jak1 and Jak2 , with reduced transcriptional output. These transcriptional and epigenetic signatures were observed in human CKD samples, where higher ACLY expression correlated with worse kidney function and increased JAK1/2 expression. Notably, ACLY inhibitors, including bempedoic acid and BMS‐303141 recapitulated the antifibrotic effects of Acly deletion in vivo in mice, supporting the therapeutic repurposing of ACLY inhibitors for CKD. Together, our findings position ACLY as a key metabolic‐epigenetic checkpoint of kidney fibrosis and a promising, druggable target for halting CKD progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institutes for Diabetes, Obesity and Metabolism, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
- Renal Electrolyte & Hypertension Division, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
- Department of Genetics, Perelman school of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
- Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
ORCID-Profile: Chunxiu Du, Yanjuan Hou, Kathryn E Wellen, Katalin Susztak
Förderung
- NIDDK NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Du, C., Mukhi, D., Li, L., Li, C., Pan, S., Dumoulin, B., Ha, E., Kolligundla, L. P., Hou, Y., Levinsohn, J., Kang, C., Klötzer, K. A., Wu, J., Mohandes, S., Wellen, K. E., & Susztak, K. (2026). ACLY‐Driven Metabolic Reprogramming Promotes Histone Acetylation and Inflammation‐Associated Fibrosis in Chronic Kidney Disease. Advanced Science. https://doi.org/10.1002/advs.75247
Vancouver
Du C, Mukhi D, Li L, Li C, Pan S, Dumoulin B, et al. ACLY‐Driven Metabolic Reprogramming Promotes Histone Acetylation and Inflammation‐Associated Fibrosis in Chronic Kidney Disease. Advanced Science. 2026. doi:10.1002/advs.75247
BibTeX
@article{Du2026,
author = {Du, Chunxiu and Mukhi, Dhanunjay and Li, Lingzhi and Li, Chenyu and Pan, Siyu and Dumoulin, Bernhard and Ha, Eunji and Kolligundla, Lakshmi P and Hou, Yanjuan and Levinsohn, Jonathan and Kang, Chaelin and Klötzer, Konstantin Adrian and Wu, Junnan and Mohandes, Samer and Wellen, Kathryn E and Susztak, Katalin},
title = {ACLY‐Driven Metabolic Reprogramming Promotes Histone Acetylation and Inflammation‐Associated Fibrosis in Chronic Kidney Disease},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.75247}
}
EUVIMED